Cellectis (CLLS) Assets (QoQ) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn |
| 10 | Cellectis | 20.83 Bn | 20.62 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -10.94% |
| Dec 31, 2025 | -5.34% |
| Sep 30, 2025 | -3.09% |
| Jun 30, 2025 | -2.78% |
| Mar 31, 2025 | -5.07% |
| Dec 31, 2024 | -3.12% |
| Sep 30, 2024 | -2.77% |
| Jun 30, 2024 | 14.86% |
| Mar 31, 2024 | 6.04% |
| Dec 31, 2023 | 59.40% |
| Sep 30, 2023 | -7.89% |
| Jun 30, 2023 | -9.44% |
| Sep 30, 2022 | -12.87% |
| Jun 30, 2022 | -7.58% |
| Sep 30, 2021 | -9.76% |
| Jun 30, 2021 | 3.36% |
| Mar 31, 2021 | -5.70% |
| Dec 31, 2020 | -3.19% |
| Sep 30, 2020 | 2.59% |
| Jun 30, 2020 | 0.33% |
| Mar 31, 2020 | 0.78% |
| Dec 31, 2019 | -2.71% |
| Sep 30, 2019 | -4.92% |
| Jun 30, 2019 | -1.29% |
| Mar 31, 2019 | 2.22% |
| Dec 31, 2018 | -3.65% |
| Sep 30, 2018 | -2.67% |
| Jun 30, 2018 | 64.81% |
| Mar 31, 2018 | -2.65% |
| Dec 31, 2017 | -4.73% |
| Sep 30, 2017 | 10.61% |
| Jun 30, 2017 | -2.77% |
| Mar 31, 2017 | -4.31% |
| Dec 31, 2016 | -3.19% |
| Sep 30, 2016 | -3.73% |
| Jun 30, 2016 | 4.96% |
| Mar 31, 2016 | -7.17% |
| Dec 31, 2015 | 11.25% |
| Sep 30, 2015 | -1.04% |
| Jun 30, 2015 | -11.54% |
| Mar 31, 2015 | 123.19% |